Health-related quality of life in individuals with Chronic hand eczema - Findings from the multinational CHECK study
No Thumbnail Available
Authors
Bewley, Anthony
Molin, Sonja
Crépy, Marie-Noëlle
Giménez-Arnau, Ana-Maria
Brignoli, Lysel
Rault, Bleuenn
Bark, Claire
Norlin, Jenny M.
Fargnoli, Maria Concetta
Apfelbacher, Christian
Contact
Check for full-text access
Issue Date
2026
Type
Article
Language
Keywords
Alternative Title
Abstract
Chronic hand eczema (CHE) is a complex, multifactorial inflammatory skin disease that significantly impairs patients' quality of life. Objectives:This multinational, prospective, observational study evaluated the burden of CHE on health-related quality of life (HRQoL) in adults across six countries: Canada, France, Germany, Italy, Spain, and the United Kingdom. Methods:Participants who self-reported a physician-diagnosed CHE completed the patient-reported outcome measures, including the Hand Eczema Impact Scale (HEIS), Dermatology Life Quality Index (DLQI), and EQ-5D 5 Level Version (EQ-5D-5L). Data were stratified by disease severity, history of suboptimal response to topical corticosteroids (TCS), and current treatment type. Results:Results demonstrated a substantial HRQoL burden associated with CHE, specifically in participants with moderate to severe CHE compared to those with mild CHE (DLQI: 7.7 ± 6.3 vs 3.7 ± 4.7; EQ-5D-5L: 0.682 ± 0.259 vs 0.742 ± 0.237; HEIS total score: 1.5 ± 1.0 vs 0.7 ± 0.8; p < 0.001 for all). A particularly high burden was reported among participants for whom TCS was suboptimal and those receiving systemics/phototherapy. Conclusions:Present study findings highlight the need for more effective management strategies and targeted treatment options to improve the HRQoL of individuals suffering from CHE.
Description
Citation
Publisher
License
Journal
The Journal of dermatological treatment
Volume
37
Issue
1